BLNK: B-Cell Linker Protein

A key adaptor protein in B-cell receptor signaling and immune development

Gene Information Card

Symbol BLNK
Full Name B-cell linker protein
Gene Type protein-coding
Chromosomal Location 10q23.2-q23.31
NCBI Gene ID 29760 ncbi.nlm.nih.gov/gene/29760
Ensembl ID ENSG00000100092
UniProt ID Q8WV28
OMIM ID 604515
HGNC ID 1058
Aliases SLP-65, BASH, bca, Ly57

Description

BLNK (B-cell linker protein) is a cytoplasmic adaptor protein essential for B-cell receptor (BCR) signaling. It bridges the BCR-associated kinases SYK and BTK to downstream effectors such as PLCG2, leading to calcium mobilization, MAPK activation, and transcriptional regulation. BLNK is critical for B-cell development, maturation, and immune response. Mutations in BLNK cause autosomal recessive agammaglobulinemia type 4 (AGM4), characterized by early-onset recurrent infections and absence of mature B cells.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Agammaglobulinemia type 4 (AGM4) Loss-of-function mutations in BLNK disrupt BCR signaling, blocking B-cell development at the pro-B to pre-B cell transition. OMIM #613502; PubMed: 10581030
B-cell acute lymphoblastic leukemia (B-ALL) BLNK acts as a tumor suppressor; reduced expression or epigenetic silencing contributes to leukemogenesis. PubMed: 15187023; COSMIC
Systemic lupus erythematosus (SLE) BLNK polymorphisms may alter B-cell activation thresholds, increasing autoantibody production. PubMed: 17376145

Expression Profile

Tissue Expression
Tissue nTPM level
Spleen 12.5 High
Lymph node 10.8 High
Bone marrow 8.2 Medium
Blood 6.1 Medium
Appendix 5.4 Medium
Lung 0.8 Low
Cell Line Expression
Cell Line nTPM Notes
Raji (Burkitt lymphoma) 15.3 B-cell line
Daudi (Burkitt lymphoma) 14.1 B-cell line
K562 (leukemia) 0.2 Non-B cell control
HEK293 (embryonic kidney) 0.1 Non-hematopoietic control
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.676C>T (p.Arg226*) Nonsense Rare Loss of function; truncated protein lacking SH2 domain
c.1A>G (p.Met1?) Start loss Rare No protein translation
c.130_131del (p.Leu44fs) Frameshift Rare Premature stop; complete loss of function
c.835G>A (p.Gly279Arg) Missense Rare Impaired SYK binding and phosphorylation
Mutation functional classification

Loss of Function (LOF)

Most BLNK mutations are loss-of-function, leading to truncated or unstable protein, defective BCR signaling, and arrested B-cell development.

Gain of Function (GOF)

No gain-of-function mutations reported in BLNK.

Dominant Negative (DN)

No dominant-negative mutations reported; BLNK deficiency is recessive.

Pathways

• B cell receptor signaling pathway (KEGG hsa04662)
• Primary immunodeficiency (KEGG hsa05340)
• Fc gamma R-mediated phagocytosis (KEGG hsa04666)

Protein Summary

BLNK is a 456-amino-acid adaptor protein with an N-terminal leucine zipper motif, a central proline-rich region, and a C-terminal SH2 domain. It lacks intrinsic enzymatic activity but serves as a scaffold for SYK, BTK, PLCG2, and GRB2. Upon BCR engagement, BLNK is phosphorylated by SYK, creating docking sites for downstream effectors. This protein is predominantly expressed in B cells and is essential for B-cell maturation and antibody production.

Related Products

Product name Cat.No. Species Gene ID
BLNK Knockout HEK293 Cell Line EDJ-KQ544 Human 29760 Details Get a Quote
BLNK Knockout HeLa Cell Line EDJ-KQ56107 Human 29760 Details Get a Quote
BLNK Knockout A-549 Cell Line EDJ-KQ64593 Human 29760 Details Get a Quote
BLNK Knockout HCT 116 Cell Line EDJ-KQ73047 Human 29760 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: